INCI · — · CIR review pending · used in 1 products
비스-에톡시다이글라이콜사이클로헥산1,4-다이카복실레이트
BIS-ETHOXYDIGLYCOL CYCLOHEXANE 1,4-DICARBOXYLATE
Evidence level
moderateEWG score
—Comedogenic
—Category
—● Benefits
Benefits to be documented.
● Cautions
No known cautions documented in the catalog.
